Buckingham Strategic Wealth’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $55.1K | Buy |
17,820
+100
| +0.6% | +$309 | ﹤0.01% | 751 |
|
|
2024
Q1 | $45.7K | Hold |
17,720
| – | – | ﹤0.01% | 745 |
|
|
2023
Q4 | $44.3K | Hold |
17,720
| – | – | ﹤0.01% | 712 |
|
|
2023
Q3 | $36K | Hold |
17,720
| – | – | ﹤0.01% | 680 |
|
|
2023
Q2 | $40.8K | Hold |
17,720
| – | – | ﹤0.01% | 682 |
|
|
2023
Q1 | $41.3K | Hold |
17,720
| – | – | ﹤0.01% | 604 |
|
|
2022
Q4 | $41.3K | Hold |
17,720
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $34K | Sell |
17,720
-11
| -0.1% | -$21 | ﹤0.01% | 592 |
|
|
2022
Q2 | $48K | Buy |
17,731
+11
| +0.1% | +$30 | ﹤0.01% | 587 |
|
|
2022
Q1 | $53K | Buy |
17,720
+5,000
| +39% | +$15K | ﹤0.01% | 585 |
|
|
2021
Q4 | $49K | Hold |
12,720
| – | – | ﹤0.01% | 588 |
|
|
2021
Q3 | $55K | Buy |
12,720
+1,000
| +9% | +$4.32K | ﹤0.01% | 582 |
|
|
2021
Q2 | $36K | Buy |
+11,720
| New | +$36K | ﹤0.01% | 584 |
|